Note: A path to efficient gene editing

Note: A path to efficient gene editing

- August 12, 2021

Note: A path to efficient gene editing

Doi: 10.1038/s41591-018-0110-y

Gene editing in human pluripotent stem cells (hPSCs) and iPSC -- the efficiency is very low compared to the other cell types.

Kaykas and colleagues and Taipale and colleagues

finding p53 antagonizing efficient genome editing using Cas9 in hPSC and immortalized human retinal pigment epithelial cells
Editing gene that is silent in hPSCs -- > same result as editing one that active
Single DSB induced by Cas9 in the genome of hPSC -- > reduces their survival
Cas9 screens in transformed cells

Copy number of gene target (rather than nature of individual genes) -- > drive phenotype of edited cells

Thus -- clinical applications -- this could cause undesired side effects

Kaykas and colleagues

Study transcriptional response of hPSC using gene editing with Cas9
Even one single strand break -- > increases expression of genes involved in programmed cell death
Cas9-induced toxicity is mediated by p53
Reduced the levels, or function, of p53 in the cells and found that this dramatically reduced Cas9-induced toxicity and—more importantly—increased the number of hPSCs with an edited genome that survived

Taipale and colleagues

Precise edits in the genome of hPSCs is antagonized by p53, and they also observed an increased efficiency of editing in hRPE cells in which p53 function was reduced.

For gene editing which used DSB-based

Transient suppression of p53is well-tolerated by hPSCs, and, on the basis of the provided data, it clearly could be an option for experiments in which efficient DSB-based engineering of their genome is required.

ZFN and TAL

Safety is good

ZFN-edited human hematopoietic stem and progenitor cells

NCT02500849 and NCT03432364 -- underway

Important point

Transient suppression of p53 -- > cause accumulation of mutations -- > later on causing unk side effect

Comments